Marksans-Pharma Stock/Share Prices, Buy and Sell Marksans-Pharma BSE Stocks

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

19 Sep 2018 | 04:01 PM

35.00

-1.15 (-3.18%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-19.63%

Return (1Y)

Underperformed S&P BSE Healthcare by 35.25%
More Volatile

3.25%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.19%
Inconsistent Performer

3/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Marksans Pharma schedules AGM
16 days ago

Marksans Pharma schedules AGM

03 - Sep - 2018 12:00 AM | 16 days ago

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2018.
Powered by Capital Market - Live News
Marksans Pharma standalone net profit rises 1095.69% in the June 2018 quarter
44 days ago

Marksans Pharma standalone net profit rises 1095.69% in the June 2018 quarter

06 - Aug - 2018 12:00 AM | 44 days ago

Net profit of Marksans Pharma rose 1095.69% to Rs 13.87 crore in the quarter ended June 2018 as against Rs 1.16 crore during the previous quarter ended June 2017. Sales rose 77.78% to Rs 93.14 crore in the quarter ended June 2018 as against Rs 52.39 crore during the previous quarter ended June 2017.
Particulars Quarter Ended
Jun. 2018 Jun. 2017 % Var.
Sales 93.14 52.39 78
OPM % 18.34 14.96 -
PBDT 18.80 6.56 187
PBT 16.68 2.75 507
NP 13.87 1.16 1096
Powered by Capital Market - Live News
Marksans Pharma consolidated net profit rises 72.54% in the June 2018 quarter
44 days ago

Marksans Pharma consolidated net profit rises 72.54% in the June 2018 quarter

06 - Aug - 2018 12:00 AM | 44 days ago

Net profit of Marksans Pharma rose 72.54% to Rs 24.88 crore in the quarter ended June 2018 as against Rs 14.42 crore during the previous quarter ended June 2017. Sales rose 6.42% to Rs 235.25 crore in the quarter ended June 2018 as against Rs 221.06 crore during the previous quarter ended June 2017.
Particulars Quarter Ended
Jun. 2018 Jun. 2017 % Var.
Sales 235.25 221.06 6
OPM % 15.09 13.12 -
PBDT 36.32 27.10 34
PBT 30.36 19.66 54
NP 24.88 14.42 73
Powered by Capital Market - Live News

Marksans Pharma reports consolidated net loss of Rs 4.03 crore in the March 2018 quarter

98 days ago

Price vs Volume

Stock Trivia

FII shareholding in Marksans Pharma Ltd has increased by 35.76% since past 3 Months
FII shareholding in Marksans Pharma Ltd has decreased by -49.7% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended			Year Ended
	Mar. 2018	Mar. 2017	% Var.	Mar. 2018	Mar. 2017	% Var.
Sales	199.39	184.75	8	912.69	767.16	19
OPM %	2.04	0.45	-	9.48	5.83	-
PBDT	0.51	6.18	-92	76.64	44.99	70
PBT	-5.68	-1.36	-318	49.80	14.90	234
NP	-4.03	-3.22	-25	35.80	11.34	216

Particulars	Quarter Ended
	Jun. 2018	Jun. 2017	% Var.
Sales	93.14	52.39	78
OPM %	18.34	14.96	-
PBDT	18.80	6.56	187
PBT	16.68	2.75	507
NP	13.87	1.16	1096

Particulars	Quarter Ended
	Jun. 2018	Jun. 2017	% Var.
Sales	235.25	221.06	6
OPM %	15.09	13.12	-
PBDT	36.32	27.10	34
PBT	30.36	19.66	54
NP	24.88	14.42	73

General Notifications

My Notifications

Research Notifications

Marksans Pharma Ltd NSE / BSE Pharmaceuticals, Mid Cap

35.00 -1.15 (-3.18%)

News & Announcements

Price vs Volume

Stock Trivia

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

35.00

-1.15 (-3.18%)